Bevacizumab Treatment and Retinal Vessel Monitoring

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

April 30, 2009

Conditions
Cancer
Interventions
DRUG

bevacizumab treatment

single infusion 10 mg/kg

Trial Locations (1)

01307

Autonomic lab (ANF), Dresden

All Listed Sponsors
lead

Technische Universität Dresden

OTHER

NCT00740168 - Bevacizumab Treatment and Retinal Vessel Monitoring | Biotech Hunter | Biotech Hunter